Good news, good news, read all about it. The controversial disease of our century could be cured with a new and revolutionary combo of substances that efficiently act to kill off the affection.
Aromatase inhibitors and bisphosphonates mixed together showed extremely promising results, of 40% decrease in death risk for post-menopausal women with early stages of breast cancer.
Aromatase inhibitors are used in hormone suppressing treatments prescribed for women with postmenopausal and ovarian cancer. Bisphosphonates are used in treatments for osteoporosis. A mix of two always acts better than one, and experts have managed to find the perfect, affordable combo between treatments which can successfully cure breast cancer in its first stages.
A team of researchers at the University of Oxford in UK embarked on a mission to discover the new and revolutionary combination of drugs. If taken together, they provide great chances of battling against breast cancer. Furthermore, the mix manages to cut the mortality rate among post-menopausal women.
The new discovery was performed through a large study that involved 30.000 post-menopausal women who had developed breast cancer. The patients were subjected to nine medical trials that highlighted a dramatic decrease in the number of deaths.
First of all, patients were given aromatase inhibitors to efficiently treat their endocrine system in order to hinder the recurrence of the disease. As a result, in five years the fatality risk decreased by 21% compared to patients given tamoxifen, another drug used on cancer patients. Aromatase inhibitors weakened the bones in some individuals, as each and every drug comes with its batch of side effects. That was the moment when the second drug entered the study. Bisphosphonates is an efficient drug, highly used to fight weakening of the bones of osteoporosis in post-menopausal women. Combined with aromatase inhibitors, it showed amazing results after experimented in cancer patients.
To strengthen the results, researchers conducted a second part of the study, involving the mix of two substances. The second research involved 20.000 participants in 26 randomized trials. Conclusions were amazing. Women who took the mix of treatments showed lack of side effects and dropped their breast cancer risk recurrence by one third. The combo also reduced mortality rate by 15% from the 21% reported on a previous study.
Good news don’t end here, as both the drugs are extremely affordable. One doesn’t need to pay large amounts of money to face the disastrous effects of breast cancer. The simple way is most of the times the most efficient way and the new discovery is here to prove that. Breast cancer is one of the most widely spread types of cancer in women, affecting 25% of reported cases of cancer, resulting in 522.000 deaths on a yearly basis. According to the last statistic released in 2012, there were 1.68 million deaths reported.
Image Source: ediets.com
